HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$1.68
Day range
$1.65 - $1.77
Year range
$1.52 - $6.08
Market cap
148.74M USD
Avg Volume
1.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 8.60M | -32.98% |
Operating expense | 11.22M | -17.33% |
Net income | -19.62M | 4.97% |
Net profit margin | -228.05 | -41.79% |
Earnings per share | -0.22 | 24.14% |
EBITDA | -17.59M | -14.72% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.70M | -34.96% |
Total assets | 123.96M | -16.35% |
Total liabilities | 85.42M | 14.22% |
Total equity | 38.54M | — |
Shares outstanding | 90.32M | — |
Price to book | 3.91 | — |
Return on assets | -36.13% | — |
Return on capital | -40.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.62M | 4.97% |
Cash from operations | -7.70M | 40.68% |
Cash from investing | 6.39M | 316.63% |
Cash from financing | -111.00K | -100.37% |
Net change in cash | -1.43M | -107.57% |
Free cash flow | -907.62K | 88.68% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
188
